These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22000587)

  • 1. [Atypical calciphylaxis secondary to treatment with acenocoumarol].
    Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2012; 103(1):79-81. PubMed ID: 22000587
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical calciphylaxis secondary to treatment with acenocoumarol.
    Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2012 Jan; 103(1):79-81. PubMed ID: 22444506
    [No Abstract]   [Full Text] [Related]  

  • 3. Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of.
    Wenstedt EFE; Huysentruyt CJ; Konings CJAM
    Neth J Med; 2017 May; 75(4):161-164. PubMed ID: 28522774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-uremic calciphylaxis due to acenocoumarol].
    Torres-Bondia FI; Parada-Saavedra FJ; Fernández-Armenteros JM; Schoenenberger-Arnaiz JA
    Farm Hosp; 2017 Jul; 41(4):569-570. PubMed ID: 28683713
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of acenocoumarol-associated calciphylaxis with drug withdrawal.
    Suárez-Peñaranda JM; Minasyan A; Sainz-Gaspar L; Sánchez-Aguilar MD
    Australas J Dermatol; 2019 Aug; 60(3):e223-e226. PubMed ID: 30790279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sodium thiosulfate for the treatment of acenocumarol-induced calciphylaxis in a patient with preserved kidney function].
    Mateos Egido E; Álamo Medina A; Ródenas Gálvez AC; Lombardero Pin M; Díez Del Pino A
    Farm Hosp; 2017 May; 41(3):425-427. PubMed ID: 28478757
    [No Abstract]   [Full Text] [Related]  

  • 7. Calciphylaxis in a diabetic patient provoked by warfarin therapy.
    Asobie N; Wong E; Cook MG
    Clin Exp Dermatol; 2008 May; 33(3):342-4. PubMed ID: 18419610
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin-induced skin necrosis progressing to calciphylaxis.
    Breakey W; Hall C; Vann Jones S; Husain A; Kernohan M
    J Plast Reconstr Aesthet Surg; 2014 Oct; 67(10):e244-6. PubMed ID: 24953291
    [No Abstract]   [Full Text] [Related]  

  • 9. Extensive coumarin-induced skin necrosis in a patient with acquired protein C deficiency.
    Argaud L; Guerin C; Thomas L; Fournier G
    Intensive Care Med; 2001 Sep; 27(9):1555. PubMed ID: 11685354
    [No Abstract]   [Full Text] [Related]  

  • 10. [Necrosis of the skin after 3 year's treatment with acenocoumarin].
    Cameron AR; van Berkel W; Sixma JJ
    Ned Tijdschr Geneeskd; 1974 Apr; 118(14):505-7. PubMed ID: 4820739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acenocoumarol as the trigger of disseminated intravascular coagulation in a patient with cancer].
    Rodríguez JA; Aguilera MC; Galende del Canto J; García MA
    Sangre (Barc); 1999 Dec; 44(6):490-1. PubMed ID: 10822766
    [No Abstract]   [Full Text] [Related]  

  • 12. Acenocoumarol-induced leukocytoclastic vasculitis.
    Jiménez-Gonzalo FJ; Medina-Pérez M; Marín-Martín J
    Haematologica; 1999 May; 84(5):462-3. PubMed ID: 10329927
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin lesions in calciphylaxis.
    Kirby LC; Abdulnabi K
    Br J Hosp Med (Lond); 2016 Jun; 77(6):371. PubMed ID: 27269760
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acenocoumarol and vasculitis - a rare case].
    Abreu P; Duarte C; Malcata A
    Acta Reumatol Port; 2010; 35(3):366-9. PubMed ID: 20975642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acenocoumarol and vasculitis: a case report.
    Aouam K; Gassab A; Khorchani H; Bel Hadj Ali H; Amri M; Boughattas NA; Zili JE
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):113-4. PubMed ID: 16981216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete mammary necrosis due to acenocoumarol.
    Pérez-Guarinos CV; García-García ML; Verdú-Fernández Mde L; Aguayo-Albasini JL
    Cir Esp; 2015; 93(7):472. PubMed ID: 26026907
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible interaction between topical terbinafine and acenocoumarol.
    Morales-Molina JA; Arrebola MA; Robles PA; Mangana JC
    Ann Pharmacother; 2009 Nov; 43(11):1911-2. PubMed ID: 19843835
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed Allergic Reaction to Acenocoumarol With a Positive Lymphocyte Transformation Test.
    Dominguez-Ortega J; Entrala A; Pola-Bibian B; Gonzalez-Muñoz M; Fiandor A; Quirce S
    J Investig Allergol Clin Immunol; 2016; 26(4):273-4. PubMed ID: 27470649
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapidly progressive nonuremic calciphylaxis in the setting of warfarin.
    Bae GH; Nambudiri VE; Bach DQ; Danziger J; Faulkner-Jones B; McMahon C; Huang SJ
    Am J Med; 2015 Oct; 128(10):e19-21. PubMed ID: 26164564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary drug toxiderma to acenocoumarol].
    Khammassi N; Kessentini N
    Pan Afr Med J; 2015; 22():95. PubMed ID: 26848342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.